3.01 USD
↘ 0.02 (0.66%)AT CLOSE (11:59 AM EDT)
Altimmune, Inc. Common Stock
ALTNASDAQ • USD
3.02
↗ 0.01 (0.33%)
POST MARKET (AS OF 07:44 PM EDT)
Post Market
AS OF 07:44 PM EDT
3.02
↗ 0.01 (0.33%)
Market: CLOSED
Shares of Altimmune, Inc. Common Stock (ALT) are trading at $3.01. There is a divergence between signals — technical indicators rate "Buy" but underlying fundamentals lean "Sell". Notable factors include a robust Altman Z-Score, a weak Piotroski F-Score of 0/9, negative Return on Equity and a bearish Death Cross on the long-term moving averages. Valuation metrics place ALT at a fair price relative to peers.
Technical & fundamental data as of Aug 6, 2026.
Open?$3.03
High?$3.05
Low?$2.95
Prev. Close?$3.03
Volume?4.0M
Avg. Volume?4.7M
VWAP?$3.00
Rel. Volume?0.84x
Bid / Ask
Bid?$3.00 × 100
Ask?$3.03 × 2.3K
Spread?$0.03
Midpoint?$3.01
Valuation & Ratios
Market Cap?589.3M
Shares Out?194.5M
Float?104.2M
Float %?92.4%
P/E Ratio?N/A
P/B Ratio?2.07
EPS?-$0.47
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Altimmune Inc is a late clinical-stage biopharmaceutical company developing therapies for patients with serious liver diseases. The Company's key candidate, pemvidutide, is a dual-action therapy targeting both glucagon and GLP-1 receptors in a balanced 1:1 ratio in development for the treatment of metabolic dysfunction-associated steatohepatitis (MASH), alcohol use disorder (AUD), and alcohol-associated liver disease (ALD). The company also plans to pursue additional indications for pemvidutide that leverage the differentiated clinical profile of pemvidutide.
Employees
57
Market Cap
589.3M
Industry
PHARMACEUTICAL PREPARATIONS
Website
Listed
2005-10-06
Address
910 CLOPPER ROAD
GAITHERSBURG, MD 20878
Phone: (240) 654-1450
GAITHERSBURG, MD 20878
Phone: (240) 654-1450
Technical OutlookBuy
Strong SellNeutralStrong Buy
Long-Term (Tide)?▲ Bullish(+1/3)
Medium-Term (Wave)?▲ Bullish(+2/3)
Short-Term (Ripple)?– Neutral(0/3)
MA Alignment?Mixed
Full Technical Analysis →Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?3
Z-Score?94
Momentum?50
Short Sent.?10
Piotroski F-Score?0/9Weak
Altman Z-Score?4.25Safe
Confidence?45%Low
Short InterestSqueeze Risk
Short % of Float?46.29%Squeeze Risk
Short Interest?48.2M
Days to Cover?12.5
Free Float104.2M
Avg Daily Volume3.9M
Settlement Date2026-07-15
Financial Health
Current Ratio?29.56Strong
Quick Ratio?29.56Strong
Cash Ratio?8.62Strong
Debt/Equity?0.12Low
ValuationFAIRLY VALUEDvs 1 peers + S&P 500
Score67/100
P/E?N/A▾
P/B?2.07CHEAP▾
Peers100
S&P73
P/S?16,368.24HIGH▾
Peers100
S&P3
P/FCF?N/A▾
EV/EBITDA?-5.4CHEAP▾
S&P97
EV/Sales?14,615.57HIGH▾
Peers100
S&P3
Returns & Efficiency
ROE?-32.2%WEAK▾
S&P6
ROA?-27.2%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?$-71669000
Enterprise Value?$526.2M
Fundamentals ratios updated end of day